Stock Track | MBX Biosciences Plummets 5.08% Intraday on Negative Earnings Expectations

Stock Track

Mar 14

MBX Biosciences' stock price plummeted 5.08% during intraday trading on Friday, as the company faces negative earnings expectations ahead of its upcoming financial report.

According to recent earnings preview data, MBX Biosciences is expected to report a loss of 58 cents per share for the period ending March 31, 2026, with the company anticipated to show no change in quarterly revenue when it reports results on May 11. While the mean earnings estimate has risen by about 10.9% in the last three months, the continued projected losses appear to have weighed on investor sentiment.

The stock's decline comes despite Wall Street's median 12-month price target of $63.00, representing approximately 125.4% upside from its previous closing price of $27.95, and an overall "buy" rating from analysts with 10 "strong buy" or "buy" recommendations versus just 1 "sell" or "strong sell" rating.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1151954255"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151954255\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151954255?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-14 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151954255","market":"us","top_or_hot":-1,"title":"Stock Track | MBX Biosciences Plummets 5.08% Intraday on Negative Earnings Expectations","media":"Stock Track","content":"<p>MBX Biosciences' stock price plummeted 5.08% during intraday trading on Friday, as the company faces negative earnings expectations ahead of its upcoming financial report.</p><p>According to recent earnings preview data, MBX Biosciences is expected to report a loss of 58 cents per share for the period ending March 31, 2026, with the company anticipated to show no change in quarterly revenue when it reports results on May 11. While the mean earnings estimate has risen by about 10.9% in the last three months, the continued projected losses appear to have weighed on investor sentiment.</p><p>The stock's decline comes despite Wall Street's median 12-month price target of $63.00, representing approximately 125.4% upside from its previous closing price of $27.95, and an overall \"buy\" rating from analysts with 10 \"strong buy\" or \"buy\" recommendations versus just 1 \"sell\" or \"strong sell\" rating.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MBX Biosciences Plummets 5.08% Intraday on Negative Earnings Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MBX Biosciences Plummets 5.08% Intraday on Negative Earnings Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-14 00:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MBX Biosciences' stock price plummeted 5.08% during intraday trading on Friday, as the company faces negative earnings expectations ahead of its upcoming financial report.</p><p>According to recent earnings preview data, MBX Biosciences is expected to report a loss of 58 cents per share for the period ending March 31, 2026, with the company anticipated to show no change in quarterly revenue when it reports results on May 11. While the mean earnings estimate has risen by about 10.9% in the last three months, the continued projected losses appear to have weighed on investor sentiment.</p><p>The stock's decline comes despite Wall Street's median 12-month price target of $63.00, representing approximately 125.4% upside from its previous closing price of $27.95, and an overall \"buy\" rating from analysts with 10 \"strong buy\" or \"buy\" recommendations versus just 1 \"sell\" or \"strong sell\" rating.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MBX","symbol_name":"MBX Biosciences","start_time":0,"source_url":"","article_id":"1151954255","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151954255","pubTimestamp":1773419667,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MBX Biosciences' stock price plummeted 5.08% during intraday trading on Friday, as the company faces negative earnings expectations ahead of its upcoming financial report.According to recent earnings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MBX":"MBX Biosciences"},"translate_title":"个股追踪|MBX Biosciences盘中暴跌5.08%因盈利预期为负","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MBX":1},"content_text":"MBX Biosciences' stock price plummeted 5.08% during intraday trading on Friday, as the company faces negative earnings expectations ahead of its upcoming financial report.According to recent earnings preview data, MBX Biosciences is expected to report a loss of 58 cents per share for the period ending March 31, 2026, with the company anticipated to show no change in quarterly revenue when it reports results on May 11. While the mean earnings estimate has risen by about 10.9% in the last three months, the continued projected losses appear to have weighed on investor sentiment.The stock's decline comes despite Wall Street's median 12-month price target of $63.00, representing approximately 125.4% upside from its previous closing price of $27.95, and an overall \"buy\" rating from analysts with 10 \"strong buy\" or \"buy\" recommendations versus just 1 \"sell\" or \"strong sell\" rating.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}